medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 3, 2024
Abstract
Understanding
the
dynamics
of
antibody
responses
following
vaccination
and
SARS-CoV-2
infection
is
important
for
informing
effective
strategies
other
public
health
interventions.
This
study
investigates
in
a
Puerto
Rican
cohort,
analyzing
how
IgG
levels
vary
by
status
previous
infection.
We
assess
waning
immunity
distribution
hybrid
with
aim
to
inform
programs
Rico
similar
settings.
conducted
prospective,
longitudinal
cohort
identify
infections
related
outcomes
Ponce,
Rico,
from
June
2020–August
2022.
Participants
provided
self-collected
nasal
swabs
every
week
serum
six
months
RT-PCR
testing,
respectively.
reactivity
against
nucleocapsid
(N)
antigens,
which
generally
indicate
infection,
spike
(S1)
receptor-binding
domain
(RBD)
history
either
or
vaccination,
was
assessed
using
Luminex
Corporation
xMAP®
Multi-Antigen
Assay.
Prior
defined
positive
RT-PCRs,
categorized
predominant
circulating
variant
at
event
time.
Demographic
information,
medical
history,
COVID-19
were
collected
through
standardized
questionnaires.
Of
882
participants
included
our
analysis,
34.0%
experienced
least
one
most
(78.7%)
occurring
during
Omicron
wave
(December
2021
onwards).
prevalence
increased
over
time,
reaching
98.4%
final
collection,
67.0%
attributable
alone,
1.6%
31.4%
both.
Regardless
prior
status,
RBD
S1
gradually
declined
two
vaccine
doses.
A
third
dose
boosted
these
showed
slower
decline
N-antibody
peaked
surge
waned
Vaccination
individuals
elicited
highest
durable
responses.
N
seropositivity
associated
lower
odds
subsequent
PCR
test
period,
antibodies
showing
stronger
association.
By
elucidating
differential
decay
complexities
response
this
strengthens
foundation
developing
targeted
interventions
strategies.
SLAS DISCOVERY,
Journal Year:
2025,
Volume and Issue:
31, P. 100211 - 100211
Published: Jan. 15, 2025
The
COVID-19
pandemic
has
emphasized
the
necessity
for
rapid
and
adaptable
drug
screening
platforms
against
live
pathogenic
viruses
that
require
high
levels
of
biosafety
containment.
Conventional
antiviral
testing
is
time-consuming
labor-intensive.
Here,
we
outline
design
validation
a
semi-automated
drug-screening
platform
SARS-CoV-2
utilizes
multiple
liquid
handlers,
stable
A549
cell
line
expressing
ACE2
TMPRSS2
receptors,
recombinant
strain
harboring
nano-luciferase
gene.
This
allows
accelerated
low-,
mid-,
high-throughput
screenings
by
bypassing
virus
inactivation
staining
steps
compared
to
assays
utilizing
fluorescent
reporter
or
immunofluorescence.
First,
demonstrated
luminescence
signal
obtained
at
24
h
post-infection
robust
can
be
used
as
surrogate
immunofluorescence
48
incubation
post
infection.
We
confirmed
susceptibility
panel
reference
drugs
validated
in
96-
384-well
plates
accordance
with
NIH
criteria
screening.
showed
reproducible
results,
Z
factor
≥0.5,
coefficient
variation
<20%
achieved
both
96
plate
formats.
Lastly,
assessed
assay's
performance
240
compounds
from
MMV
Global
Health
Library,
using
format
remdesivir
control
compound.
single
point
resulted
identification
hits
inhibited
more
than
50%
viral
growth.
selected
15
most
active
evaluate
their
inhibitory
concentration
cytotoxicity,
which
confirmation
3
potent
least
toxic
were
never
reported
antivirals.
These
results
confirm
our
reliably
employed
easily
adapted
other
viruses.
American Journal of Epidemiology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 19, 2024
The
test-negative
design
(TND)
is
a
popular
method
for
evaluating
vaccine
effectiveness
(VE).
A
"classical"
TND
study
includes
symptomatic
individuals
tested
the
disease
targeted
by
to
estimate
VE
against
infection.
However,
recent
applications
of
have
attempted
infection
including
all
individuals,
regardless
their
symptoms.
In
this
article,
we
use
directed
acyclic
graphs
and
simulations
investigate
potential
biases
in
studies
COVID-19
arising
from
"alternative"
approach,
particularly
when
applied
during
periods
widespread
testing.
We
show
that
inclusion
asymptomatic
can
potentially
lead
collider
stratification
bias,
uncontrolled
confounding
health
healthcare-seeking
behaviors
(HSBs),
differential
outcome
misclassification.
While
our
focus
on
setting,
issues
discussed
here
may
also
be
relevant
context
other
infectious
diseases.
This
true
scenarios
where
there
either
high
baseline
prevalence
infection,
strong
correlation
between
HSBs
vaccination,
different
testing
practices
vaccinated
unvaccinated
or
settings
both
under
attenuates
symptoms
diagnostic
accuracy
modified
presence
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 8, 2025
Abstract
The
objective
of
this
study
was
to
investigate
the
features
immune
protection
against
SARS-CoV-2
infection
in
a
single
cohort
during
6–17
months
following
booster
immunization
with
an
mRNA-based
vaccine.
results
illustrate
influence
humoral
and
cellular
immunity
on
efficacy
Notably,
neutralizing
antibody
titers
were
found
serve
as
reasonably
reliable
correlate
prior
immunization.
However,
predictive
power
largely
lost
after
boosting.
loss
appears
be
due
critical
remodeling
response
Our
findings
support
hypothesis
that
both
conserved
non-conserved
epitopes
viral
Spike
protein's
receptor-binding
domain
(RBD)
is
crucial
for
optimal
long-term
Omicron
infection.
While
may
provide
cross-variant
protection,
antibodies
targeting
RBD
play
pivotal
role
achieving
maximum
protection.
These
observations
highlight
repeated
shaping
landscape
reinforce
necessity
considering
components,
alongside
intended
use
considerations,
when
assessing
vaccine
developing
future
strategies.
Expert Review of Anti-infective Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 23, 2025
Lower
respiratory
infections
have
a
huge
impact
on
global
health,
especially
in
older
individuals,
immunocompromised
people,
and
those
with
chronic
comorbidities.
The
COVID-19
pandemic
highlights
the
importance
of
vaccination.
However,
there
are
lower
rates
vaccination
adult
population
that
commonly
due
to
missed
opportunity
vaccinate.
Vaccination
offers
best
strategy
prevent
hospitalization,
complications,
death
caused
by
infections.
In
this
review,
authors
provide
an
overview
vaccines
for
population.
review
available
data
about
preventing
infections,
focusing
pneumococcal
vaccine,
influenza
vaccines,
syncytial
virus
(RSV)
vaccines.
discuss
currently
scientific
evidence
role
against
Finally,
current
recommendations
Scientific
effectiveness
is
important.
An
efficient
implementation
immunization
strategies
will
decrease
burden
Recognizing
existing
their
essential
achieve
high
rate
European Respiratory Review,
Journal Year:
2025,
Volume and Issue:
34(175), P. 240222 - 240222
Published: Jan. 1, 2025
Background
Up-to-date
evidence
from
European
studies
on
long-term
vaccine
effectiveness
(VE)
of
COVID-19
vaccines
is
lacking.
This
review
aimed
to
evaluate
and
durability
primary
series
boosters
in
preventing
infection
severe
outcomes
the
population.
Methods
We
conducted
systematic
searches
PubMed
Embase
up
22
January
2024.
included
observational
that
evaluated
VE
against
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
or
disease
(hospitalisation,
intensive
care
unit
admission
death)
for
Europe.
applied
a
random-effects
meta-analysis
model.
Results
33
over
56
million
participants.
The
overall
complete
with
any
SARS-CoV-2
variant
was
70.7%.
lower
Omicron,
at
26.1%,
than
pre-Omicron
strains,
77.0%.
Over
time,
by
decreased
68.9%
38.9%
after
6
months.
Boosters
restored
76.4%
maintained
58.4%
3
due
87.4%,
93.3%
62.8%
Omicron
strains.
Protection
declined
less
infection.
months
series,
still
provided
50%
protection
caused
Omicron.
87.9%
78.5%
Conclusion
declines
markedly
time
variants.
more
durable
resistant
viral
mutation.
protection,
emphasising
need
timely
booster
vaccination
vulnerable
populations.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(8), P. 1325 - 1325
Published: Aug. 4, 2023
We
carried
out
a
cohort
study
on
the
overall
population
of
province
Pescara,
Italy,
to
assess
real-world
effectiveness
SARS-CoV-2
vaccination
against
infection,
severe,
or
lethal
COVID-19,
two
years
after
start
campaign.
included
all
resident
domiciled
subjects,
and
extracted
official
demographic,
vaccination,
hospital
co-pay
exemption
datasets
from
1
January
2021,
up
15
February
2023.
Cox
proportional
hazards
analyses
were
adjusted
for
gender,
age,
diabetes,
hypertension,
COPD,
major
cardio-
cerebrovascular
events,
cancer,
kidney
diseases.
Throughout
follow-up
(466
days
average),
186,676
subjects
received
greater
than
equal
three
vaccine
doses
(of
ChAdOx1
nCoV-19,
BNT162b2,
mRNA-1273,
NVX-CoV2373,
JNJ-78436735),
47,610
doses,
11,452
one
dose,
44,989
none.
Overall,
40.4%
infected
with
SARS-CoV-2.
Of
them,
2.74%
had
severe
(1.30%)
COVID-19.
As
compared
unvaccinated,
individuals
who
booster
dose
showed
≥85%
lower
risk
A
massive
impact
was
found
among
elderly:
22.0%
died,
as
opposed
less
3%
those
doses.
No
protection
infection
observed,
although
this
finding
certainly
influenced
by
Italian
restriction
policies
control
pandemic.
Importantly,
during
Omicron
predominance
period,
only
group
at
least
reduced
COVID-19-related
death.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(11), P. 1640 - 1640
Published: Oct. 26, 2023
During
the
COVID-19
pandemic
in
Germany,
vaccination
uptake
exhibited
considerable
regional
disparities.
To
assess
factors
contributing
to
this
variation,
we
examined
association
of
sociodemographic
variables
with
COVID-19,
booster,
and
influenza
status
within
a
cohort
37,078
participants
from
13
German
federal
states
digital
health
study
commonly
known
as
DigiHero.
Our
findings
revealed
variations
rates
based
on
factors.
However,
these
had
limited
explanatory
power
regarding
differences
vaccine
uptake.
In
contrast,
found
substantial
correlations
between
support
specific
parties
during
last
local
elections
at
level
each
administrative
district.
conclusion,
alone
did
not
suffice
explain
disparities
Political
stances
can
play
major
role,
although
current
investigation
individual
political
orientations
but
rather
used
only
an
ecological
approach.
PLOS Global Public Health,
Journal Year:
2023,
Volume and Issue:
3(11), P. e0002532 - e0002532
Published: Nov. 1, 2023
Understanding
community
members'
knowledge
of
SARS-CoV-2
transmission
and
prevention
is
essential
for
directing
public
health
interventions
to
reduce
disease
spread
improve
vaccination
coverage.
Here,
we
describe
COVID-19
transmission,
prevention,
symptoms
among
residents
in
Mozambique.
We
conducted
a
cross-sectional
survey
33,087
households
Health
Demographic
Surveillance
System
Manhiça,
Participants
were
recruited
April
2021
before
the
Delta
variant
wave
peak
Omicron
cases
February
2022.
Principal
components
analysis
was
used
create
scores
representing
symptoms,
prevention.
Multiple
imputation
quasi-Poisson
regression
examine
associations
between
demographic
characteristics
sources
information,
examined
whether
information
mediated
relationship
educational
attainment
Across
this
rural
community,
98.2%,
97.0%,
85.1%
respondents
reported
knowing
how
could
be
prevented,
that
can
cause
disease,
transmitted,
respectively.
The
most
recognized
cough
(51.2%),
headaches
(44.9%),
fever
(44.5%);
mechanisms
saliva
droplets
(50.5%)
or
aerosol
(46.9%)
from
an
infected
person;
measures
handwashing
(91.9%)
mask-wearing
(91.8%).
Characteristics
associated
with
greater
included
having
at
least
primary
education,
older
age,
employment,
higher
wealth,
Christian
religion.
Respondents
who
had
experienced
also
more
likely
possess
Receiving
television,
WhatsApp,
radio,
hospital,
scores.
These
findings
support
need
outreach
community-engaged
messaging
promote
measures,
particularly
people
low
education.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 29, 2023
ABSTRACT
Objectives
As
of
May
2023,
over
500,000
COVID-19
cases
and
7,500
deaths
have
been
reported
in
Ethiopia.
Understanding
community
members’
knowledge
perception
SARS-CoV-2
prevention
is
essential
for
directing
public
health
interventions
to
reduce
transmission
improve
vaccination
coverage.
Here,
we
aimed
describe
factors
associated
with
among
residents
Eastern
Methods
We
conducted
a
cross-sectional
survey
random
sample
880
participants
Health
Demographic
Surveillance
System
the
Harari
Region,
Ethiopia,
from
August
September
2021.
Principal
components
analysis
was
used
create
score
representing
prevention.
Quasi-Poisson
regression
examine
associations
between
demographic
characteristics
Our
also
included
information
regarding
or
government
measures
prevent
COVID-19,
healthcare
services
children
under
five,
pregnant
women.
Results
The
most
cited
individual
risk
contracting
were
washing
hands
soap
(91.5%)
wearing
facemask
(89.2%),
whereas
least
mentioned
avoiding
domestic
international
travel
(22.2%)
medical
gloves
(20.3%).
recognized
closure
schools
universities
(77.0%),
advice
avoid
gatherings
(75.2%),
stay
home
(62.3%).
Adjusted
analyses
demonstrated
that
higher
rural
areas
than
urban
areas,
those
aged
≥65
years
(<25
as
reference),
secondary
education
(no
formal
monthly
income
≥2,001
Birr
(0-1,200
farmers
domestic/subsistence
workers
employees
(unemployed
reference).
Knowledge
lower
households
≥5
household
members
(1-2
Of
five
women,
9.4%
12.3%
missed
at
one
care
visit
since
mid-March
2020
consequent
pandemic,
respectively.
Conclusions
Public
infectious
disease
depend
on
perceptions
knowledge.
found
adults
had
good
methods
reducing
risks
although
differed
groups.
A
substantial
number
respondents
missing
important
visits.
these
may
help
Ethiopian
authorities
plan
effective
programs
control
SARS-CoV-2.
Life,
Journal Year:
2023,
Volume and Issue:
13(10), P. 2094 - 2094
Published: Oct. 21, 2023
Vaccination
has
been
a
game-changer
in
the
long
battle
against
COVID-19.
However,
waning
vaccine-induced
immunity
and
immune
evasion
of
emerging
variants
create
challenges.
The
rapid-fire
development
bivalent
vaccines
(BVs),
comprising
ancestral
strains
new
variant,
was
authorized
to
prevent
COVID-19,
but
effectiveness
updated
remains
largely
unclear.
Electronic
databases
were
searched
investigate
immunogenicity
reactogenicity
BVs
humans.
As
March
2023,
20
trials
identified.
Compared
with
monovalent
vaccination,
induced
similar.
demonstrated
approximately
33-50%
higher
values
additional
variant
strains.
An
observational
cohort
study
showed
clinical
BVs.
adverse
events
In
conclusion,
our
systematic
review
found
that
had
equal
without
safety
concerns.
Approximately
increased
antibody
titers
observed
subjects
BV
vaccine
moderate
heterogeneity,
especially
for
BA.1-containing